LifeStance Health Group's revenue per share for the
three
months ended in Mar. 2026 was $1.02.
LifeStance Health Group's revenue per share for the trailing twelve months (TTM) ended in Mar. 2026 was $3.79.
During the past 12 months, the average Revenue Per Share Growth Rate of LifeStance Health Group was 12.90% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 14.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for LifeStance Health Group's Revenue per Share or its related term are showing as below:
LFST'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 14.6 Med: 17.4 Max: 62
Current: 14.6
During the past 7 years, LifeStance Health Group's highest 3-Year average Revenue Per Share Growth Rate was 62.00% per year. The lowest was 14.60% per year. And the median was 17.40% per year.
LFST's 3-Year Revenue Growth Rate is ranked better than 71.94% of 613
companies
in the Healthcare Providers & Services industry
Industry Median: 7
vs LFST: 14.60
LifeStance Health Group (NAS:LFST) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
LifeStance Health Group Revenue per Share Related Terms
LifeStance Health Group Revenue per Share Historical Data
* Premium members only.
The historical data trend for LifeStance Health Group's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LFST vs CON, BKD, OPCH: Revenue per Share Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's PS Ratio falls into.
LifeStance Health Group Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
LifeStance Health Group's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a Revenue per Share of $3.79 as of Mar. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on LifeStance Health Group and its competitors. According to the industry distribution chart, LifeStance Health Group ranks #172 out of 613 companies in the Healthcare Providers & Services industry, placing it in the top 28.1%.
Is LifeStance Health Group's Revenue per Share too high?
LifeStance Health Group's current Revenue per Share is $3.79. The Healthcare Providers & Services industry median Revenue per Share is 7.00. LifeStance Health Group's value of $3.79 is 45.9% below this industry median. Based on the distribution chart, LifeStance Health Group ranks #172 out of 613 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Revenue per Share compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #172 out of 613 companies for Revenue per Share. This puts LifeStance Health Group in the upper half of its industry. The industry median Revenue per Share is 7.00. LifeStance Health Group's value of $3.79 is 45.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Healthcare Providers & Services company?
The median Revenue per Share among Healthcare Providers & Services companies is 7.00, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Revenue per Share of $3.79 is 45.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Revenue per Share is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Revenue per Share is $3.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.27, compared to a current price of $10.75 — trading 30% above its estimated fair value. The current Revenue per Share is $3.79 and 45.9% below the Healthcare Providers & Services industry median of 7.00. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Revenue per Share is $3.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.75 is trading 30% above its estimated GF Value™ of $8.27.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
Revenue per Share: $3.79
GF Value™: $8.27 vs. price of $10.75 (30% above fair value)
Industry Position: 45.9% below the Healthcare Providers & Services median (#172 of 613)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
